Gülen Hatemi Selected Research

Gülen Hatemi Research Topics

6	Oral Ulcer (Mouth Ulcer) 10/2023 - 11/2019
3	Uveitis 05/2024 - 11/2019
3	Pain (Aches) 01/2022 - 08/2021
2	Infections 11/2023 - 09/2023
2	Neoplasms (Cancer) 09/2023 - 07/2012
2	Ulcer 01/2022 - 08/2021
2	Headache (Headaches) 09/2021 - 11/2019
2	Nausea 09/2021 - 11/2019
1	Retinal Vasculitis 05/2024
1	Arthritis (Polyarthritis) 11/2023
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 11/2023
1	Psoriatic Arthritis 09/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2023
1	Psoriasis (Pustulosis Palmaris et Plantaris) 09/2023
1	Opportunistic Infections (Opportunistic Infection) 09/2023
1	Myalgia 01/2023
1	VEXAS syndrome 01/2022
1	Respiratory Tract Infections (Respiratory Tract Infection) 09/2021
1	Diarrhea 11/2019
1	Venous Thrombosis (Deep-Vein Thrombosis) 11/2019
1	Inflammation (Inflammations) 01/2019
1	Philadelphia Chromosome 07/2012
1	Thrombosis (Thrombus) 07/2012
1	Proctitis 01/2012

7	apremilastIBA 10/2023 - 11/2019
2	Infliximab (Remicade)FDA Link 10/2023 - 11/2019
1	HLA-B51 AntigenIBA 05/2024
1	HLA Antigens (Human Leukocyte Antigens)IBA 05/2024
1	HLA-B Antigens (HLA-B)IBA 05/2024
1	Proteins (Proteins, Gene)FDA Link 11/2023
1	AntigensIBA 11/2023
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 11/2023
1	omega-Chloroacetophenone (Mace)IBA 09/2023
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2022
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2022
1	EnzymesIBA 01/2022
1	Adalimumab (Humira)FDA Link 11/2019
1	ChemokinesIBA 01/2019
1	CytokinesIBA 01/2019
1	Superoxides (Superoxide)IBA 01/2019
1	AutoantibodiesIBA 01/2019
1	Janus Kinase 2IBA 07/2012

2	Therapeutics 11/2019 - 01/2012
1	Biological Therapy 01/2023